Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 Feb 1;2023:9107598. doi: 10.1155/2023/9107598

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2023 Ji Ma et al.

This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PMC Copyright notice

Pharmacophore structure analysis of dehydrovomifoliol and the seven receptor targets involved in NAFLD treatment using the PharmMapper database. (a) Pharmacophore models for the interaction of E2F1 with dehydrovomifoliol. (b) Pharmacophore models for the interaction of MERTK with dehydrovomifoliol. (c) Pharmacophore models for the interaction of SOX17 with dehydrovomifoliol. (d) Pharmacophore models for the interaction of MMP9 with dehydrovomifoliol. (e) Pharmacophore models for the interaction of SULT2A1 with dehydrovomifoliol. (f) Pharmacophore models for the interaction of VEGFA with dehydrovomifoliol. (g) Pharmacophore models for the interaction of BLVRA with dehydrovomifoliol. (h) Pharmacophore models for the interaction of E2F1, MERTK, SOX17, MMP9, SULT2A1, VEGFA, and BLVRA with dehydrovomifoliol.